PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia

NCT02805205 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

484

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: PEG-rhG-CSF

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.